Description
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Product Unit Size | Cost | Quantity | Stock |
|---|
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Cas No. | 2170137-61-6 (free base) |
|---|---|
| Purity | ≥98% |
| Formula | C16H25N5 |
| Formula Wt. | 287.41 |
| IUPAC Name | (1S,3S)-3-N-(5-pentan-3-ylpyrazolo[1,5-a]pyrimidin-7-yl)cyclopentane-1,3-diamine |
| Synonym | KB0742, NSC-834161, NSC834161 |
| Appearance | Yellow to brown crystal |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Richters A, Doyle S, Freeman D, et al. Modulating androgen receptor-driven transcription in prostate cancer with selective CDK9 inhibitors. Cell Chem Biol. 2021 Feb 18;28(2):134-147. PMID: 33086052
Purine nucleoside analog; DNA chain terminator,...
p53 activator, IMPDH and SIRT1 inhibitor.
Bosutinib isomer; Src and Abl inhibitor.
Synthetic glycyrrhetinic acid derivative; 11β-...
Endogenous peptide hormone inolved in gastric e...
PDK1 and Akt inhibitor.
Alkaloid compound originally found in Corydalis...
Carnitine derivative, involved in energy homeos...
Peptide, derivative of AT II, involved in vasoc...
ALK and IGF-1R inhibitor.
Semisynthetic flavone that acts as an inhibitor...
Proteinase subtrate.
Isoflavone found in Pueraria; 5-HT2C and GABA-A...
Triazole; demethylation inhibitor, NMDA agonist...
p53 inhibitor
Imidazole; 14-α demethylase inhibitor, potenti...
5-HT2A antagonist, potential α1-adrenergic ant...
5-HT1A agonist, 5-HT1B partial agonist, 5-HT3A/...
p110δ PI3K inhibitor.
Thio sulforaphane analog, ITC.